Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Business Bank backs a €1bn growth fund

1 min read
16:30UTC

The British Business Bank committed €65m to Highland Europe's sixth fund on 30 July, buying a limited-partner slot rather than writing a cheque into a company.

TechnologyDeveloping
Key takeaway

The Bank bought a limited-partner slot in a €1bn growth fund rather than picking companies itself.

The British Business Bank committed €65m to Highland Europe's Technology Growth Fund VI on 30 July, a vehicle above €1bn targeting companies from Series B to pre-IPO⁠1. Highland Europe has raised €3.75bn across six funds, backed more than 80 companies and seen 30 exits. The Bank is the UK's state-owned development bank; Highland Europe is a private growth-equity firm with offices in London and Geneva, and the two have already sat on the same cap table at the data company 9fin, which Christine Hockley, who runs the Bank's commercial equity funds, cited when the commitment was announced.

The commitment is a limited-partner position, not a direct investment. The Bank does not choose which companies Highland Europe backs, does not price the rounds and does not sit on the boards. What it buys instead is a claim on a fund big enough to lead the growth rounds that British companies have historically flown to New York or Silicon Valley to raise. The trade-off is control: every pound committed this way is a pound the Bank cannot aim at a specific gap it has identified.

This is the second such position in five weeks. The Bank put £10m into Odyssey Ventures' transatlantic seed fund in July, at the opposite end of the stage range. Between a seed fund and a pre-IPO growth vehicle, the Bank now has fund-of-funds exposure across almost the whole ladder, built from commitments rather than from picks.

Deep Analysis

In plain English

The British Business Bank, the UK government's economic development bank, committed €65m to a fund run by Highland Europe, a venture firm that invests in later-stage tech companies, from Series B through to just before a company goes public. Highland Europe's fund is aiming to raise more than €1bn in total. This is a fund-of-funds move: rather than picking individual companies itself, the Bank is trusting Highland Europe's team to pick winners on its behalf. Highland Europe has raised €3.75bn across six funds before this one, backed more than 80 companies, and seen 30 of them exit successfully. Christine Hockley, who runs the Bank's commercial equity funds, pointed to an existing shared investment with Highland Europe in the data company 9fin as a reason for the relationship.

What could happen next?
  • Meaning

    The Bank is using a fund-of-funds route into Highland Europe's Series B to pre-IPO vehicle rather than backing individual growth-stage companies directly.

First Reported In

Update #14 · UKRI's sponsor department no longer exists

British Business Bank· 24 Aug 2026
Read original →
Causes and effects
This Event
Business Bank backs a €1bn growth fund
A state development bank set up to invest directly is increasingly buying exposure through other people's funds, which changes who picks the companies.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.